Predicting 2-year survival in stage I-III non-small cell lung cancer: the development and validation of a scoring system from an Australian cohort

BACKGROUND: There are limited data on survival prediction models in contemporary inoperable non-small cell lung cancer (NSCLC) patients. The objective of this study was to develop and validate a survival prediction model in a cohort of inoperable stage I-III NSCLC patients treated with radiotherapy....

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Natalie Si-Yi, Shafiq, Jesmin, Field, Matthew, Fiddler, Caroline, Varadarajan, Suganthy, Gandhidasan, Senthilkumar, Hau, Eric, Vinod, Shalini Kavita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008968/
https://www.ncbi.nlm.nih.gov/pubmed/35418206
http://dx.doi.org/10.1186/s13014-022-02050-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008968/
https://www.ncbi.nlm.nih.gov/pubmed/35418206
http://dx.doi.org/10.1186/s13014-022-02050-1

Ejemplares similares